TITLE 410 INDIANA STATE DEPARTMENT OF HEALTH
Proposed Rule
LSA Document #10-504
DIGEST
Amends
410 IAC 3-3-1 to update and add new definitions. Amends
410 IAC 3-3-2 to update references. Adds
410 IAC 3-3-2.5 concerning equipment and supplies. Amends
410 IAC 3-3-3 to clarify and add diseases to the list of newborn disorders required to be screened. Amends
410 IAC 3-3-4 to clarify and add to the responsibilities of designated laboratories. Amends
410 IAC 3-3-5 to make corrections and add to requirements of laboratory reporting. Amends
410 IAC 3-3-6 to change and update procedures for the maintenance of screening logs, follow-up of missing results, and monthly reporting. Amends
410 IAC 3-3-7 to make changes to the requirements for follow-up of positive results and updates recommendations. Adds
410 IAC 3-3-9,
410 IAC 3-3-10,
410 IAC 3-3-11,
410 IAC 3-3-12, and
410 IAC 3-3-13 to add newborn hearing screening responsibilities, add and specify responsibilities for newborn hearing screening equipment and supplies, add newborn hearing screening protocols for hospital birthing facilities and midwives, add newborn hearing screening reporting requirements, update fees, and add
410 IAC 3-3-14 concerning grounds for filing a complaint. Repeals
410 IAC 3-3-7.1 and
410 IAC 3-3-8. Effective
30 days after filing with the Publisher.
Rule 3. Newborn Screening
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 1.
As used in 410 IAC 3-3: The following definitions apply throughout this rule:
(1) "Audiologist" means an audiologist licensed by the state of Indiana pursuant to the Indiana professional licensing agency board who meets the requirements outlined in Indiana's Best Practice Guidelines for Assessment who administers short-term and long-term early hearing detection and intervention (EHDI) program follow-up.
(2) "Birthing center" means any nonhospital facility in which live births routinely take place.
"Board" means the Indiana state board of health.
(3) "Child" means an individual twelve (12) months to eighteen (18) years of age.
(4) "Department" means the Indiana state department of health.
(5) "Diagnostic audiology Level 1 facility" means a facility as defined by the department that has and uses the recommended test battery and equipment for provision of comprehensive audiological assessment of newborns and infants.
(6) "EHDI follow-up" means follow-up that occurs subsequent to newborn hearing screening. Children in need of EHDI follow-up include the following:
(A) Infants not yet screened (for any reason).
(B) Infants who did not pass newborn hearing screening.
(C) Infants who passed newborn hearing screening but have a risk indicator that could lead to late-onset hearing loss.
(7) "Galactosemia" means an inherited error in the metabolism of galactose.
(8) "Hearing loss" means an impairment that is a dysfunction of the auditory system of any type or degree sufficient to interfere with acquisition and development of speech and language.
(9) "Hearing screening" means a bilateral, physiological measurement of hearing on a newborn or infant.
(10) "Hemoglobinopathy" means an a condition where a person has abnormal hemoglobin which that results from an inherited defect, some of which may produce a sickling phenomenon in erythrocytes.
(11) "Homocystinuria" means an inherited error in the metabolism of methionine.
(12) "Hospital" means a licensed hospital with obstetric services.
(13) "Hypothyroidism" means a deficient amount or activity of thyroid hormone.
(14) "Infant" means an individual who is thirty (30) days to twelve (12) months of age.
(15) "Maple syrup urine disease" means an inherited error in the metabolism of leucine, isoleucine, and valine.
"MCH" (16) "MCH/CSHCS clinics" means clinics affiliated with the children's special health care services program of the division of maternal and child health of the department that provide services to women, children, and children with special health care needs.
(17) "MCH/NBS" means division of maternal and child health, genetic diseases section, genomics and newborn screening program, at the Indiana state board of health. department.
(18) "Metabolic formula" means a nutritional supplement provided to patients diagnosed with metabolic newborn screening conditions.
(19) "Newborn" means an individual who is up to twenty-nine (29) days of age.
(20) "Parent" means a natural (birth) parent, stepparent, adoptive parent, legal guardian, or other legal custodian of an individual.
(21) "Phenylketonuria" means an inherited error in the metabolism of phenylalanine.
(22) "Satisfactory blood specimen" means a blood specimen on which an accurate laboratory analysis can be performed for the disorder for which it is submitted.
(23) "Unsatisfactory blood specimen" means any of the following:
(1) (A) A filter paper kit on which an insufficient quantity of blood is obtained.
(2) (B) A filter paper kit on which an accurate analysis or interpretation cannot be performed due to improper collection, handling, or submission or a technical or laboratory problem.
(3) (C) Cord blood.
(4) (D) Blood from any transfused neonate.
(5) (E) A filter paper kit which that does not provide all of the information regarding the patient as required. The blood specimen within such a filter paper kit may be satisfactory according to the criteria above.
410 IAC 3-3-2 Provision of testing information; religious objection
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 2. (a) The board department shall provide public educational materials, including descriptions of the disorders and of the screening program, to hospitals, birthing centers, physicians, midwives, and other health care providers for distribution to patients. Physicians and midwives engaged in providing prenatal and/or or perinatal, or both, care shall provide pregnant women, prior to the estimated date of delivery, with this information. Hospitals and birthing centers shall provide each pregnant woman admitted for delivery with a copy of this information prior to collection of the blood specimen. If a woman is unable to read such the material, it shall be translated or read to her in a language she understands.
(b) Any parent or guardian who objects to the testing for reasons pertaining to religious beliefs only shall so indicate by signing a statement of informed refusal. Such The objection shall become part of the medical record, and the infant shall be exempted from the testing.
(Indiana State Department of Health; 410 IAC 3-3-2; filed Nov 7, 1986, 3:30 p.m.: 10 IR 416; readopted filed Jul 11, 2001, 2:23 p.m.: 24 IR 4234; readopted filed May 22, 2007, 1:44 p.m.: 20070613-IR-410070141RFA)
410 IAC 3-3-2.5 Equipment and supplies for newborn screening
Authority:
IC 16-41-17
Sec. 2.5. (a) The state-contracted newborn screening laboratory will furnish filter paper kits annually to hospitals, midwives, birthing facilities, and other collections sources. Manufacturer and lot number for the filter paper must be included on the filter paper section of the kit in accordance with the Clinical Laboratory Standards Institute (CLSI)-approved national standard. Sequential system control numbers for each collection kit must be printed on each information section of the collection card and on the filter paper section, if that section is detachable.
(b) The state-contracted newborn screening laboratory must provide filter paper kits, without additional cost, to local health departments, MCH/CSHCS clinics, or other outside organizations/individuals as designated by the department for the collection of newborn screening specimens.
(c) The department's newborn screening program will ensure that all Indiana residents who are diagnosed with one (1) of the metabolic conditions included in the newborn screening panel have access to the appropriate metabolic formula necessary for treatment.
(1) A single brand of metabolic formula for each metabolic condition on the newborn screen will be designated by the state-contracted metabolic geneticist and made available to all Indiana residents as appropriate.
(2) The appropriate metabolic formula will be made available to all Indiana residents diagnosed with one (1) of the metabolic conditions included on Indiana's newborn screening panel, regardless of the individual's ability to pay or socioeconomic status.
(A) Payment for metabolic formula will be based on a sliding-fee scale as designated by the department.
(B) All efforts will be made to collect payment for metabolic formula from private insurance companies or other third-party payers.
(C) The department's newborn screening program will serve as a payer of last resort for patients without private insurance coverage or for whom reimbursement cannot be obtained from another third-party payer.
(d) All other costs related to purchasing equipment or supplies that are required to perform mandated newborn screening must be covered by the hospital, birthing facility, midwifery, or physician practice.
(Indiana State Department of Health; 410 IAC 3-3-2.5)
410 IAC 3-3-3 Screening for phenylketonuria, hypothyroidism, galactosemia, homocystinuria, maple syrup urine disease, hemoglobinopathies, congenital adrenal hyperplasia, biotinidase deficiency, cystic fibrosis, and other genetic conditions; collection procedures
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 3. (a)
Except as provided for in section 2(b) of this rule, all newborn infants born in the state of Indiana shall be screened for
the following:
(1) Phenylketonuria.
(2) Hypothyroidism.
(3) Galactosemia.
(4) Homocystinuria.
(5) Maple syrup urine disease.
(6) Hemoglobinopathies, including sickle cell anemia.
(7) Congenital adrenal hyperplasia. and
(8) Biotinidase deficiency. except as provided for in section 2(b) of this rule.
(9) Cystic fibrosis.
(10) Hearing impairment.
(11) Other genetic conditions that are detectable at birth via newborn screening methods, including, but not limited to, the following:
(A) Tandem mass spectrometry (MS/MS).
(B) High volume radioimmunoassay.
(C) Hemoglobin electrophoresis.
(D) Isoelectric focusing.
(E) Bacterial inhibition assays.
(F) Immunoreactive trypsin (IRT).
(G) DNA testing.
(b) The responsible physician, midwife, or hospital shall collect a specimen of the infant's blood on a filter paper kit approved by the board. department. The specimen shall consist of capillary blood obtained by heel puncture and applied directly to the special filter paper. All circles shall be saturated with blood from one (1) side of the filter paper only. All information requested on the form attached to the special filter paper shall be provided. The specimen shall be air dried and then inserted into the protective envelope with complete data. If multiple specimens are forwarded in one (1) envelope, care must be taken to avoid cross-contamination. Completed specimens shall be forwarded to a designated laboratory within twenty-four (24) hours after collection.
(c) The infant's blood for these tests shall be collected not earlier than forty-eight (48) hours after birth and not before the infant has been on a protein diet for at least twenty-four (24) hours, except as stated in subsection (d), and no not later than one hundred twenty (120) hours after birth, except as stated in subsection (f).
(d) When a live birth occurs in a hospital, the responsible physician shall have a specimen of the infant's blood taken prior to the infant's discharge from the hospital. If the infant is discharged from the hospital before forty-eight (48) hours after birth, or before being on a protein diet for twenty-four (24) hours, a blood specimen shall be collected regardless, but collection shall be repeated after forty-eight (48) hours and no not later than one hundred twenty (120) hours after birth. The hospital administrator or a designated representative shall provide a written notice to the parents, guardian, or other legally responsible person, at or before discharge, of the requirements for such the newborn to be tested again prior to one hundred twenty (120) hours after birth.
(e) When a live birth occurs in a facility other than a licensed hospital, it shall be the responsibility of the physician or midwife in attendance at the birth to assure that the newborn is referred to an appropriate facility, such as a physician office, hospital, or local health department, and to make the arrangements to obtain and submit a satisfactory blood specimen in accordance with this section. In the absence of an attending physician or midwife, the registrar of births shall refer the infant immediately to the parent's physician or to the local health department for submission of a specimen in accordance with this section and notify the MCH MCH/NBS immediately.
(f) For preterm infants, the specimen shall be taken on the day of discharge or on the sixth day if nursery stay is prolonged beyond six (6) days. Prematurity and transfusion status shall be noted on the request form in the space provided. If the infant is to receive total exchange transfusion, then the specimen for the newborn screening test is to be obtained from the first draw, which represents the infant's own blood.
(g) For infants within the neonatal intensive care unit (NICU), the responsible physician or hospital shall follow the routine NICU rescreening guidelines and collect specimens as specified by the department.
(Indiana State Department of Health; 410 IAC 3-3-3; filed Nov 7, 1986, 3:30 p.m.: 10 IR 416; filed Sep 17, 1999, 10:42 a.m.: 23 IR 324; errata filed Nov 19, 1999, 9:31 a.m.: 23 IR 814; readopted filed Jul 11, 2001, 2:23 p.m.: 24 IR 4234; readopted filed May 22, 2007, 1:44 p.m.: 20070613-IR-410070141RFA)
410 IAC 3-3-4 Designated laboratories; requirements to perform screening tests for disorders
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 4. An approved laboratory must meet the following requirements in order to perform screening tests for disorders on dried blood samples from newborns:
(a) (1) Complies with Public Law 90-174, the Federal Clinical Laboratory Improvement Act of 1967 or 1988, and is accredited by the College of American Pathologists, or is accredited by the Joint Commission on Accreditation of Hospitals.
(b) (2) Performs or makes reasonable assurances that it will perform each one of the above screening tests on a minimum of 25,000 newborns annually. all infants born in the state of Indiana.
(3) Performs repeat newborn screening on blood specimens annually as a follow-up to abnormal screens or screens that are not legally valid as described above.
(c) (4) Uses laboratory procedures and values for normal and abnormal test results which that have been submitted to and approved by the board. department.
(d) (5) Initiates the approved tests within twenty-four (24) hours of receipt of the specimen and the completes all approved tests shall be completed within seventy-two (72) hours of receipt of the specimen.
(e) (6) Reports findings in a timely manner and maintains records of the results of all screening and follow-up testing in accordance with the requirements of the board. department.
(f) (7) Provides at least monthly reports of its screening activities to the board. department in the format and time frame specified by the department.
(g) (8) Maintains a written quality assurance program covering all aspects of its newborn screening activity, which is approved yearly by the board. department.
(h) (9) Cooperates with other relevant agencies concerned with newborn health care.
(i) (10) Participates in a laboratory quality assurance program, including proficiency testing, approved by the board. department.
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 5.
Specific reporting/follow-up requirements vary based on whether the analysis indicated whether the specimen met all requirements for a valid screening test and whether the screening results were normal, unsatisfactory, abnormal, presumptive positive, or confirmed positive. The laboratory shall report as follows:
(a) (1) Negative test results shall be reported within seven (7) days of the date of
analysis by mail receipt of the specimen to
MCH and to the following:
(A) MCH/NBS.
(B) The hospital submitting the specimens. A copy for
(C) The responsible physician. shall be included for distribution by the hospital.
The report of the test results shall become part of the patient's clinical record.
(2) Presumptive positive tests shall be reported immediately by telephone to the hospital, birthing facility, midwife, or collection source. The notification shall be recorded in the laboratory's records, specifying date and time of notification, person notified, and information provided. This shall be followed by an official report within three (3) days. The report of the test result shall become part of the patient's clinical record. If there is no known responsible physician, the appropriate state-contracted newborn screening follow-up specialist shall be notified.
(b) (3) Confirmed positive tests shall be reported immediately by telephone to the hospital, responsible physician, and to MCH. Such MCH/NBS. The notification shall be recorded in the laboratory's records specifying date and time of notification, person notified, and information provided. This shall be followed by a written an official report within three (3) days. The report of the test result shall become part of the patient's clinical record. If there is no known responsible physician, the local health officer in the county of the mother's residence shall be notified.
(c) (4) Unsatisfactory specimens shall be reported immediately by telephone to the hospital and responsible physician or other health care provider submitting the specimen with an explanation about the reason for rejection. In the event that the responsible physician or health care provider who submitted the specimen is no longer the primary health care provider, he or she shall be responsible for notifying the current primary health care provider.
(d) (5) In the event a specimen is rejected for any reason as unsatisfactory, the physician responsible for the infant's care at the time of the report shall be responsible for the submission of an acceptable specimen within forty-eight (48) business hours. If the laboratory does not receive the repeat specimen within five (5) days, it shall notify MCH send the hospital/collection source and responsible physician notification of the requirement for a repeat screen, with a copy provided for MCH/NBS. A reminder will be sent five (5) business days after the initial notification if no repeat specimen has been received. The laboratory will notify MCH/NBS immediately by telephone if no repeat specimen has been received seven (7) to ten (10) business days after the reminder letter has been sent so that public health nurse assistance can be obtained.
(e) (6) The designated laboratories performing the tests shall maintain records of the results of all screening and follow-up testing of infants for these conditions in accordance with Indiana requirements for records management.
(f) (7) The laboratory shall
also provide
at least a monthly report to the board which shall contain:
(1) The number of infants tested.
(2) The number of repeat tests.
(3) The number of unacceptable specimens by hospital, birthing center, physician, or other health care provider submitting the specimen.
(4) Presumptive positive results by test.
(5) Confirmed positive results by test, including patient names and identifying information.
newborn heel-stick and hearing screening reports to the department in the format, media, and time frame specified by the department.
410 IAC 3-3-6 Maintenance of screening logs; follow-up of missing results; monthly reports as submitted by hospitals, birthing facilities, midwives, and physicians providing home birth services
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 6. (a) Each hospital,
and birthing center, and midwife or physician submitting screening tests on infants born outside a hospital or birthing center shall maintain a newborn screening log
which that shall contain the following:
(1) Name of infant.
(2) Attending physician.
(3) Medical record number.
(4) Form number of sample sent.
(5) Date sample collected.
(6) Date sample sent.
(7) Date results received.
(8) What the results were.
(9) Name of person notified of positive results and date and time of notification.
All such information and records shall be confidential but shall be open to examination by the board department personnel or its designated agents for any purpose directly connected with the administration of the newborn screening program.
(b) The log shall be reviewed daily to determine that the results of required tests have been recorded within fourteen (14) days of discharge, or that a parent's or legal guardian's signed refusal religious waiver has been filed in the newborn's medical record.
(c) Whenever a hospital, birthing center, or midwife determines that a discharged newborn has not received the mandated tests, the hospital, birthing center, or midwife shall immediately contact the responsible physician by telephone to inform him or her that a specimen must be obtained and immediately send a written notification to the responsible physician and MCH. MCH/NBS. If the responsible physician cannot be contacted within three (3) days or will not obtain a specimen, the hospital, birthing center, or midwife shall notify MCH MCH/NBS immediately by telephone and shall send written notification within three (3) days to MCH. MCH MCH/NBS. MCH/NBS shall then immediately notify the local health officer, who shall arrange collection of a specimen.
(d) Whenever a hospital, birthing center, or midwife determines that a specimen has been obtained but there are no results available in the newborn's medical record within fourteen (14) days of discharge, the hospital, birthing center, or midwife shall obtain the results from the laboratory by telephone and request that another written copy be sent. The hospital, birthing center, or midwife shall also notify
MCH MCH/NBS that results have not been received. If no results are available from the laboratory, then the hospital, birthing center, or midwife shall proceed as in
410 IAC 3-3-7(c). section 7(c) of this rule.
(e) When the responsible physician is notified by telephone by the hospital, birthing center, or midwife that a newborn was discharged before a specimen was taken, or if the physician determines from his or her own records that no test has been performed or that no results are available, the responsible physician shall make every reasonable effort to have a specimen obtained within three (3) days of notification. If the responsible physician cannot obtain the specimen, the physician shall notify MCH MCH/NBS immediately by telephone. Such The telephone notification shall be noted in the responsible physician's record, specifying the date of notification, the person notified, and the information provided.
(f) When the responsible physician is notified by the laboratory by telephone that a specimen is inadequate, the physician so notified shall make every reasonable effort to have an adequate repeat specimen obtained within forty-eight (48) hours of notification. If the responsible physician so notified cannot obtain the repeat specimen, the physician shall notify MCH MCH/NBS immediately by telephone. Such The telephone notification shall be noted in the responsible physician's records specifying the time and date of notification, the person notified, and the information provided.
(g) All repeat specimens shall be forwarded to a designated laboratory within twelve (12) hours after they have been obtained.
(h) MCH MCH/NBS shall make every reasonable effort to follow up on all newborns who that have been reported as not having received a completed screening in an attempt to ensure that all infants born in the state of Indiana will have received the required screening for disorders.
(i) Hospitals, and birthing centers, and midwives, and physicians providing home birth services shall provide monthly reports to the board department indicating the total number of live births and the number of newborns for whom specimens were submitted for initial newborn screening. for phenylketonuria, hypothyroidism, galactosemia, maple syrup urine disease, homocystinuria and hemoglobinopathy, and the total number of positive results by test with patient identifying information.
(Indiana State Department of Health; 410 IAC 3-3-6; filed Nov 7, 1986, 3:30 p.m.: 10 IR 418; readopted filed Jul 11, 2001, 2:23 p.m.: 24 IR 4234; readopted filed May 22, 2007, 1:44 p.m.: 20070613-IR-410070141RFA)
410 IAC 3-3-7 Follow-up of positive results, recommendations
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 7. (a) When the responsible physician is notified by telephone by the laboratory of an initial presumptive positive test result, the responsible physician shall obtain the board department approved repeat blood specimen from the newborn and submit it to the designated laboratory within forty-eight (48) hours. If the blood specimen cannot be obtained within forty-eight (48) hours, the responsible physician shall notify MCH MCH/NBS by telephone. Such The telephone notification shall be noted in the responsible physician's records, specifying the date of notification, the person notified, and the information provided. MCH MCH/NBS will notify the local health officer and provide the necessary follow-up to ensure that the repeat blood specimen is obtained.
(b) It shall be the responsibility of the responsible physician or, if none, the local health officer to report
the following immediately to the parent or guardian:
(1) All abnormal results from the newborn screening test in order to recommend appropriate diagnostic and possible therapeutic procedures. and
(2) Any diagnosis of a disorder in order to recommend appropriate therapeutic procedures and psychosocial support.
(c) When the repeat blood specimen supports a presumptive diagnosis of a disorder, the laboratory shall notify MCH MCH/NBS and the responsible physician or local health officer, as appropriate.
(d) When the responsible physician is notified of a presumptive positive or abnormal newborn screening result for a patient in the neonatal intensive care unit (NICU), regardless of whether the specimen was an initial or routine repeat specimen, the responsible physician shall provide follow-up as outlined above.
(d) (e) The responsible physician retains responsibility for the child's case management as the primary health care provider and shall make arrangements for the necessary diagnosis, therapy, and genetic counseling about the clinical and etiologic nature of the disorder, the chance of recurrence in subsequent children and other family members, existing resources for comprehensive clinical management, and family emotional and financial support. These can be provided directly by the responsible physician or by referral to appropriate specialists.
(e) (f) The
board department shall advise the responsible physician of the available referrals and programs for further evaluation,
genetic counseling, and management available to the patient and family. These shall include, but are not limited to, care by
the following:
(1) A clinical biochemical geneticist for children with
the following:
(A) Phenylketonuria.
(B) Galactosemia.
(C) Maple syrup urine disease. and
(D) Homocystinuria. care by
(E) Other metabolic conditions included on the newborn screen.
(2) A pediatric hematologist for children with a clinically significant hemoglobinopathy. and care by
(3) A pediatric pulmonologist for children with cystic fibrosis.
(4) A pediatric endocrinologist for children with hypothyroidism or congenital adrenal hyperplasia.
(5) An audiologist, otolaryngologist, or other specialist for children with hearing loss.
In the case of children identified as carriers of an inherited hemoglobin abnormality (individuals with trait), the board department shall recommend further evaluation of parents and appropriate counseling.
(f) (g) All physicians
and audiologists making an initial diagnosis of a treatable disorder for which testing is required under
IC 16-8-6 IC 16-41-17 shall report such diagnosis and the information necessary for follow-up to the
board. department. The reporting is mandatory for physicians and audiologists making the initial diagnosis and should be reported in the format and media approved by the department. Physicians
and audiologists caring for Indiana newborns who have been diagnosed outside the state of Indiana with a disorder for which testing is required under
IC 16-8-6 IC 16-41-17 shall report in a similar manner.
(g) (h) The
board department shall maintain
the following:
(1) A tracking system for follow-up of newborn screening results. and shall maintain
(2) A confidential registry of every infant born for whom the diagnosis of:
(A) phenylketonuria;
(B) hypothyroidism;
(C) galactosemia;
(D) maple syrup urine disease;
(E) homocystinuria; or
(F) hemoglobinopathy;
(G) cystic fibrosis;
(H) hearing loss; or
(I) another metabolic or endocrine condition;
has been confirmed.
These records shall be utilized only for the purpose of service delivery and program administration and shall be managed in accordance with
the procedures described in 410 IAC 1-2-2. 410 IAC 21-3.
(h) (i) The board department shall develop and maintain a statewide network of genetic evaluation and counseling services. Regional genetic services centers and outreach services from these centers shall serve as local evaluation and counseling resources for the follow-up program described in this section.
(Indiana State Department of Health; 410 IAC 3-3-7; filed Nov 7, 1986, 3:30 p.m.: 10 IR 419; filed Feb 25, 1988, 4:30 p.m.: 11 IR 2579; readopted filed Jul 11, 2001, 2:23 p.m.: 24 IR 4234; readopted filed May 22, 2007, 1:44 p.m.: 20070613-IR-410070141RFA)
410 IAC 3-3-9 Newborn hearing screening responsibilities
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 9. (a) The department's early hearing and detection intervention (EHDI) program is:
(1) located organizationally within the department's newborn screening program; and
(2) the program responsible for ensuring that all infants born in the state of Indiana receive appropriate newborn hearing screening and follow-up as necessary.
As the responsibilities, protocols, and reporting requirements for hearing screening differ from those for traditional heel-stick newborn screening, separate sections were created for newborn hearing screening.
(b) As outlined in section 3 of this rule, all infants born in the state of Indiana shall be screened for hearing loss.
(c) The department's EHDI program shall be the lead coordinating agency in Indiana responsible for development, implementation, and coordination of the EHDI system and oversight of the EHDI process. The department shall administer the EHDI program in a manner consistent with the most current version of the joint committee on infant hearing (JCIH) position statement.
(d) Hospitals, physicians, audiologists, and all other personnel shall comply with these timelines by assisting the department's EHDI program through early assessment, prompt referral, and prompt reporting via the specified reporting method or methods to the department's EHDI program.
(e) Each hospital birthing facility shall do the following:
(1) Designate a person to be responsible for the universal newborn hearing screening (UNHS) program in that facility. This person will act as the single point of contact between the facility and the department. This person shall ensure all personnel performing UNHS are appropriately trained and develop a quality assurance/performance improvement component of the facility's UNHS program to ensure compliance with all EHDI program rules, regulations, and guidelines.
(2) Make a reasonable effort to do the following:
(A) Perform newborn hearing screening for each infant prior to the infant's discharge.
(B) Rescreen newborns that do not pass the initial newborn hearing screening prior to the infant's discharge.
(3) Report newborn hearing screening results to the newborn's primary care provider and to the department as specified in section 12 of this rule.
(Indiana State Department of Health; 410 IAC 3-3-9)
410 IAC 3-3-10 Equipment and supplies for newborn hearing screening
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 10. (a) All materials and supplies required to perform newborn hearing screening are the responsibility of the screening facility.
(b) Each screening facility shall calibrate the screening equipment annually or according to the manufacturer's guidelines. Each screening facility shall provide a copy of the manufacturer's guidelines to the department upon request.
(c) Educational materials, including a hearing screening certificate, shall be provided to the baby's mother or guardian by the screening facility.
(Indiana State Department of Health; 410 IAC 3-3-10)
410 IAC 3-3-11 Hearing screening protocols for hospital birthing facilities and midwives
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 11. (a) Prior to the hearing screening of a newborn infant, the hospital shall provide information explaining the importance of newborn hearing screening and follow-up in writing to the infant's parents or guardians.
(b) The responsible physician, midwife, or hospital shall conduct a hearing screening of the infant's ears via the recommended method or methods as accepted by the department. Hearing screening shall mean a test to detect hearing thresholds of thirty (30) decibels (dB) or greater in the speech frequency range of each ear.
(c) The infant's hearing should be screened after six (6) hours of age and prior to discharge.
(1) Preterm infants (born prior to thirty-five (35) weeks gestational age) who stay in the nursery greater than five (5) days should have hearing screening when the baby is medically stable, but prior to discharge.
(2) Babies who reside for greater than five (5) days in the neonatal intensive care unit (NICU), especially those who have complicated birth factors, are considered to be at significantly greater risk for types of neural hearing loss, such as auditory neuropathy/dyssynchrony. These babies should receive hearing screening or diagnostic testing, or both, as recommended by the department.
(3) When possible, inpatient diagnostic testing shall be made available to long-stay infants who do not pass the initial newborn hearing screening and one (1) rescreen (for a total of two (2) hearing screenings).
(d) The only acceptable reason for not screening the hearing of an infant is if the parent or guardian of the newborn objects, in writing, to the screening based on religious beliefs.
(e) If a newborn is transferred to another hospital prior to receiving newborn hearing screening, the responsibility for completing the newborn hearing screening is shared between the birth and transferred facilities. If newborn hearing screening occurs at the transferred hospital, hearing screening results should be shared with the birth hospital via the reporting method and format specified by the department's early hearing and detection intervention (EHDI) program.
(f) If an infant is not successfully screened or did not receive a newborn hearing screening prior to discharge, the hospital shall provide an outpatient hearing screening for this infant.
(g) For infants who do not pass the initial newborn hearing screening, hearing should be rescreened one (1) additional time in both ears (regardless of previous screening results) prior to and as close to discharge as possible (for a total of two (2) hearing screenings). Preterm infants (born prior to thirty-five (35) weeks gestational age) who do not pass the initial newborn hearing screening should be rescreened one (1) additional time in both ears (regardless of previous screening results) prior to and as close as possible to discharge (for a total of two (2) hearing screenings).
(h) If an infant does not pass:
(1) his or her newborn hearing screening; and
(2) the rescreen prior to discharge;
for a total of two (2) hearing screenings, the birth hospital shall contact an approved diagnostic audiology Level 1 facility to schedule an appointment for an outpatient diagnostic hearing test. The birth hospital shall provide the location, date, and time of the appointment to the infant's mother or guardian, primary care provider, and the department's EHDI program.
(i) Inpatient diagnostic testing shall be made available, when possible, for long-stay infants who do not pass the initial newborn hearing screening and one (1) rescreen (for a total of two (2) hearing screenings).
(j) If an infant passes the newborn hearing screening, but has risk indicators for late-onset or progressive hearing loss, the hospital shall do the following:
(1) Inform the infant's mother or guardian in writing of the risk indicator.
(2) Provide written documentation of language and hearing milestones.
(3) Recommend a follow-up test at an approved diagnostic audiology Level 1 facility to be done when the infant is between nine (9) and twelve (12) months of age.
This information shall also be provided in writing to the infant's primary care provider and to the department's EHDI program via the reporting method and format specified by the department's EHDI program.
(k) Midwives shall follow all newborn hearing screening protocols as outlined for birth hospitals. Newborn hearing screening should be performed on all newborns prior to one (1) month of age, using portable equipment if needed.
(1) If midwives cannot provide direct screening for the newborns in their care, they shall have a designated referral site for these newborns to receive the hearing screening prior to one (1) month of age.
(2) If an infant does not pass:
(A) his or her newborn hearing screening; and
(B) a second hearing screening;
the midwife shall contact an approved diagnostic audiology Level 1 facility to schedule an appointment for an outpatient diagnostic hearing test. The midwife shall provide the location, date, and time of the appointment to the infant's mother or guardian, primary care provider, and the department's EHDI program.
(l) Diagnostic audiology Level 1 facilities must meet the following requirements in order to perform diagnostic hearing evaluations on infants referred from newborn hearing screening programs:
(1) The audiologist or audiologists:
(A) must be licensed by the state of Indiana; and
(B) shall have experience in performing diagnostic audiological assessments of newborns and infants.
(2) The facility:
(A) shall conduct the assessment in accordance with Indiana's Best Practice Guidelines For Audiologic Assessment, Pediatric Amplification, and Intervention of the Infant; and
(B) must have and routinely use recommended equipment for infant diagnostic testing.
(Indiana State Department of Health; 410 IAC 3-3-11)
410 IAC 3-3-12 Newborn hearing screening reports
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 12. (a) Hearing screening results shall be provided in writing to the infant's mother or guardian prior to discharge.
(b) Hearing screening results (from the hearing screening equipment or from the heel-stick card) for every child that receives a screen shall be provided to the department's early hearing detection and intervention (EHDI) program in the format, media, and time specified by the department's EHDI program.
(c) The birth hospital shall report all screening exceptions within five (5) business days, including the following:
(1) Babies who are not screened due to equipment or hospital error.
(2) Babies who do not pass the initial newborn hearing screening and one (1) additional rescreen prior to discharge (for a total of two (2) hearing screenings).
(3) Babies at risk for late-onset hearing loss.
(d) If an infant is not successfully screened or did not receive a newborn hearing screening prior to discharge, the birth hospital shall report these results as follows:
(1) To the infant's mother or guardian orally and in writing.
(2) To the infant's primary care provider and the department's EHDI program.
(e) If an infant does not pass his or her newborn hearing screening and does not pass the rescreen prior to discharge (for a total of two (2) hearing screenings), the birth hospital shall report these results as follows:
(1) To the infant's mother or guardian orally and in writing.
(2) To the infant's primary care provider and the department's EHDI program.
(3) The birth hospital shall also contact an approved diagnostic audiology Level 1 facility and schedule an appointment for an outpatient diagnostic hearing test. The location, date, and time of the appointment shall be provided to the infant's primary care provider and the department's EHDI program.
(f) If an infant passes the newborn hearing screening, but has risk indicators for late-onset or progressive hearing loss, the birth hospital shall do the following:
(1) Inform the child's mother or guardian of the risk indicator in writing.
(2) Provide the child's mother or guardian with written documentation of language and hearing milestones.
(3) Recommend a follow-up test at an approved diagnostic audiology Level 1 facility to be done when the infant is between nine (9) and twelve (12) months of age.
(4) Provide documentation of the hearing screening results, risk indicator, language and hearing milestones, and recommendation for follow-up test to the child's primary care provider in writing.
(5) Report the hearing screening results and risk indicator to the department's EHDI program.
(g) Each birth hospital shall complete and submit to the department's EHDI program a monthly summary report (MSR) by the fifteenth day of the following month. MSR data shall be submitted in the format and media specified by the department's EHDI program.
(h) Newborn hearing screening reports to be completed by midwives shall comply with the following:
(1) Midwives shall report all newborn hearing screening results to the child's primary care provider (if designated) and to the department's EHDI program.
(2) Midwives shall report all infants who:
(A) did not receive a newborn hearing screening;
(B) did not pass a newborn hearing screening; or
(C) passed the newborn hearing screening but have a risk indicator for late-onset hearing loss;
to the department's EHDI program.
(3) Each midwife facility or independent midwife must complete an MSR by the fifteenth day of the following month.
(i) Diagnostic audiology Level 1 facilities shall report results of diagnostic audiological evaluations as follows:
(1) Results shall be reported for each ear separately.
(2) Assessment results shall be reported to the department's EHDI program, regardless of audiological findings.
(3) Results shall include a statement of the severity and type of hearing loss identified.
(4) Results shall be reported within five (5) business days following the assessment.
(j) Each screening facility shall report the following items to the department's EHDI program in the reporting method and format specified by the department:
(1) The name of the person at the screening facility designated as the point of contact.
(2) The type of hearing screening equipment utilized.
(3) Equipment calibration records.
(4) Whether the hearing screening program at that screening facility is conducted by screening facility personnel or is contracted to an outside entity.
(5) Name or names of person or persons providing staff training on equipment.
(6) Name or names of person or persons competent to perform hearing screenings at the screening facility.
(7) Hearing screening protocols.
(8) Test procedure or procedures used by the screening facility's universal newborn hearing screening program.
(9) Pass criteria that minimally meet guidelines established by the department's EHDI program.
(10) A description of the screening facility quality assurance/quality improvement program.
(k) By reporting all audiologic findings to the department as outlined above, audiologists meet the reporting requirements of the Indiana birth defects and problems registry (IBDPR) for children who are diagnosed with permanent hearing loss between birth and three (3) years of age.
(Indiana State Department of Health; 410 IAC 3-3-12)
410 IAC 3-3-13 Newborn screening fund; fees; disposition; reporting requirements
Authority:
IC 16-19-3-4;
IC 16-41-17-9;
IC 16-41-17-10
Sec. 13. (a) The program involving the department and MCH/NBS as described in this rule shall be funded by the collection of a newborn screening fee for each initial newborn screening performed. The designated laboratory shall assess and collect the full amount of the newborn screening fee from hospitals, birthing centers, public health nurses, physicians, and midwives submitting newborn screening specimens. No surcharge will be assessed, collected, or reported for infants receiving repeat screens. The accumulated collections from the newborn screening fees shall be submitted on a monthly basis by the designated laboratory to the division of finance at the department. Payments shall be postmarked not later than five (5) days after the close of the preceding month. The designated laboratory shall also submit a monthly report on the number of newborns screened. Revenues submitted by the laboratory shall correspond with the number of newborns screened.
(b) The newborn screening fee shall be thirty dollars ($30) based on the projected cost of the program described in this rule and the estimated number of newborns per year. The fees shall be deposited in the newborn screening fund. Funds for the program described in this rule shall be disbursed by the department in accordance with normal procedures prescribed by the state budget agency and the state board of accounts. The fee shall be reviewed annually by the department.
(Indiana State Department of Health; 410 IAC 3-3-13)
410 IAC 3-3-14 Grounds for filing a complaint
Authority:
IC 16-19-3-4;
IC 16-41-17-9
Sec. 14. The willful or repeated failure of any:
(1) physician;
(2) midwife;
(3) laboratory;
(4) hospital;
(5) birthing center; or
(6) other health care provider;
to comply with the provisions of this rule shall, in addition to any other penalty prescribed by law, constitute grounds for filing a complaint with the individual's or institution's licensing board in addition to other legal remedies.
(Indiana State Department of Health; 410 IAC 3-3-14)
Posted: 11/02/2011 by Legislative Services Agency
DIN: 20111102-IR-410100504PRA
Composed: Apr 25,2024 4:45:50AM EDT
A
PDF version of this document.
